Over the last 9 years Medacta® has actively promoted the AMIS® (Anterior Minimally Invasive Surgery) for Hip Arthroplasty. The result of this effort is that we can now proudly announce that in June 2013, we reached 100,000 AMIS® procedures worldwide.
The success of the AMIS® approach can be attributed to several factors. Along with the inherent benefits of the anterior approach (the only technique that follows a path both intermuscular and internervous considerably reducing the risk of damage to periarticular structures), the AMIS® approach has extensive clinical experience (as indicated by the 100,000 AMIS® surgeries already performed), a specific Educational Programme (that improves the understanding of the anterior approach) and dedicated implants and instruments. All of these characteristics help to make the anterior approach simpler, stable and reproducible. In addition, Medacta® have created patient specific educational material to fully inform hip replacement patients of the benefits of AMIS®.
AMIS® offers a complete range of services which help to keep Medacta® one step ahead and making us the recognised global leader in the promotion, standardisation and education of the Anterior Approach.
However, our success would not be possible without the surgeons that work with us. To them, a big thank you for their support.